The brain-pelvis axis and why some patients need more than surgery
Central sensitisation is the process by which the central nervous system — spinal cord and brain — becomes hyper-responsive to pain signals. What began as a local mechanical problem in the pelvis gradually becomes a whole-nervous-system condition. This shift explains why some patients continue to suffer after successful nerve decompression, and why imaging can look 'normal' in a person with disabling pain.
How the pelvis rewires the brain
Prolonged pudendal or sciatic irritation drives repetitive nociceptive input into the dorsal horn of the spinal cord. Over months, this input alters synaptic strength, reduces descending inhibition and expands receptive fields. Areas of the brain that process pain — the insula, anterior cingulate cortex and thalamus — begin to fire in response to normally innocuous stimuli. Light touch becomes uncomfortable, and previously neutral activities such as sitting or urinating start to trigger pain.
Recognising central sensitisation in clinic
Suggestive features include pain spread beyond the original anatomical territory, hypersensitivity to touch and cold, sleep disturbance, cognitive fog, fatigue, and heightened sensitivity to sound or light. Validated tools such as the Central Sensitisation Inventory (CSI) help quantify the phenomenon and guide treatment intensity.
A brain-and-body treatment framework
The 2026 evidence base supports a combined approach: (1) peripheral optimisation to remove ongoing nociceptive drive — nerve blocks, physiotherapy, and decompression where indicated; (2) pharmacological down-regulation of the sensitised nervous system using gabapentinoids, low-dose tricyclics or SNRIs; (3) graded activity and pain-neuroscience education to re-establish safe movement; and (4) cognitive-behavioural or acceptance-based therapy to reduce fear-avoidance.
Realistic expectations
Central sensitisation is reversible but slowly. Meaningful improvement usually takes 6–18 months of consistent multimodal care. Patients who understand the neuroscience behind their symptoms recover measurably faster than those who do not — making patient education one of the highest-yield elements of the entire protocol.